Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C26677
http://purl.obolibrary.org/obo/NCIT_C26677
|
|---|---|
| Preferred Name | Virulizin |
| Definitions |
A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue. Viruzlin may enhance cell-mediated immune response to tumor cells by direct macrophage activation. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue. Viruzlin may enhance cell-mediated immune response to tumor cells by direct macrophage activation. (NCI04) |
|---|---|
| prefLabel | Virulizin
|
| label | Virulizin
|
| PDQ_Closed_Trial_Search_ID | 257159
|
| code | C26677
|
| prefixIRI | NCIT:C26677
|
| in_subset | |
| Preferred_Name | Virulizin
|
| FDA_UNII_Code | E5SF1Z7U1S
|
| Contributing_Source | FDA
|
| Maps_To | Virulizin
|
| CAS_Registry | 216586-46-8
|
| NCI_Drug_Dictionary_ID | 257159
|
| Legacy Concept Name | Virulizin
|
| type | |
| ALT_DEFINITION | A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 257159
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C0254455
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |